DGAP-News: MediClin AG: In 2008 sales increased by nearly 65 million Euro through internal and external growth


MediClin AG / Preliminary Results

06.03.2009 

Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------

Frankfurt, March 6, 2009 - MEDICLIN Aktiengesellschaft (MediClin) has
achieved sales of 456.8 million Euro in the financial year 2008. This is an
increase of 64.8 million Euro against previous year's figure, whereof 51.7
million Euro are attributable to the Kraichgau-Klinik Group. A preliminary
Group operating profit of 15.8 million Euro was achieved down by 3.1
million Euro compared to the previous year's figure due to an about 8
million Euro higher rental payment. The result attributable to shareholders
of MediClin accounts for 7.0 million Euro (previous year: 5.7 million
Euro).

Group occupancy rate increased by 2%-points up to 86.2% compared to 2007

The occupancy rate increased in all three segments. Thus cost increases
could be compensated especially the cost of materials. The cost of
materials ratio rose from 21.5% (2007) to 23.1%, the staff cost ratio
decrease from 55.5% (2007) to 54.6% due to higher sales. Other operating
expense went up by 14.8 million Euro to 83.4 million Euro containing about
8 million Euro more rental payment in 2008.

The number of staff accounted in full-time employees was 5,816 (2007: 5,277
full-time employees) on average in 2008. Investments (gross additions to
property, plant and equipment) amounted to 18.0 million Euro (2007: 27.6
million Euro). The cash flow from operating activities increased to 21.5
million Euro (2007: 11,3 Mio. Euro).

The balance press conference and the analyst conference will take place on
March 25, 2009 in Frankfurt. As from that date the Annual Report 2008 will
be available at www.mediclin.de.

Key figures - preliminary yoy comparison and quarterly development Group
and segments

in million Euro  Q1 Q2 Q3 Q4 2008 2007
Group sales  109.3 116.3 116.1 115.1 456.8 392.0
Consolidated operating 
result   0.4 4.8 7.1 3.5 15.8 18.9
Consolidated result
attributable to 
shareholders  -1.5 2.9 4.7 0.9 7.0 5.7
Eps in Euro (undilited) -0.03 0.06 0.10 0.02 0.15 0.18
in million Euro  Q1 Q2 Q3 Q4 2008 2007
Post-acute      
sales   57.7 62.4 63.6 61.9 245.6 225.6
segment result  -3.3 1.2 3.0 -0.7 0.2 3.2
Acute      
Sales   48.9 51.1 49.7 50.5 200.2 156.1
Segment results  3.9 3.7 4.2 3.8 15.6 16.1
Nursing care      
Sales   2.7 2.8 2.8 2.7 11.0 10.3
Segment results  -0.2 -0.1 -0.1 0.4 0.0 -0.4


About MediClin AG (Ticker: MED; WKN: 659 510)

MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neurosciences as well as Orthopaedic. With 33
clinics and seven nursing care facilities and three Medizinische
Versorgungszentren (medical care units) in eleven federal states MediClin
has a total capacity of approximately 7,900 beds. MediClin's facilities
include acute care clinics, i.e., general hospitals, special treatment
facilities, specialised hospitals and clinics for post-acute treatment and
medical rehabilitation. MediClin has approximately 7,800 employees.
DGAP 06.03.2009 
---------------------------------------------------------------------------
Language:     English
Issuer:       MediClin AG
              Westhafenplatz 1
              60327 Frankfurt
              Deutschland
Phone:        +49 (0)781 488-189
Fax:          +49 (0)781 488-184
E-mail:       alexandra.muehr@mediclin.de
Internet:     www.mediclin.de
ISIN:         DE0006595101
WKN:          659510
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Stuttgart, München, Hamburg, Düsseldorf
End of News                                     DGAP News-Service
---------------------------------------------------------------------------